Literature DB >> 32859628

Recurrent Fusion of the GRB2 Associated Binding Protein 1 (GAB1) Gene With ABL Proto-oncogene 1 (ABL1) in Benign Pediatric Soft Tissue Tumors.

Ioannis Panagopoulos1, Ludmila Gorunova2, Kristin Andersen2, Svetlana Tafjord3, Marius Lund-Iversen3, Ingvild Lobmaier3, Francesca Micci2, Sverre Heim2,4.   

Abstract

BACKGROUND/AIM: Fusions of the ABL proto-oncogene 1 gene (ABL1 in 9q34) are common in leukemias but rare in solid tumors. The most notable is the t(9;22)(q34;q11)/BCR-ABL1 coding for a chimeric tyrosine kinase. We herein report an ABL1-fusion in a pediatric tumor.
MATERIALS AND METHODS: G-banding, fluorescence in situ hybridization, reverse transcription polymerase chain reaction and Sanger sequencing were performed on a soft tissue perineurioma found in the left musculus erector spinae of a child.
RESULTS: A der(4)t(4;9)(q31;q34) and a fusion of the GRB2 associated binding protein 1 (GAB1 in 4q31) gene with ABL1 were found. A literature search revealed 3 more cases with similar genetic and clinicopathological characteristics: a soft tissue perineurioma with t(2;9;4)(p23;q34;q31) and ABL1 rearrangement, a soft tissue angiofibroma with a GAB1-ABL1 chimeric gene, and a solitary fibrous tumor carrying a der(4)t(4;9)(q31.1;q34).
CONCLUSION: GAB1-ABL1 is a recurrent fusion gene in benign pediatric tumors. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  ABL1; Benign pediatric soft tissue tumors; GAB1; GAB1-ABL1 fusion gene; chromosome translocation; der(4)t(4;9)(q31;q34); pediatric; soft tissue perineurioma

Mesh:

Substances:

Year:  2020        PMID: 32859628      PMCID: PMC7472458          DOI: 10.21873/cgp.20206

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  64 in total

1.  Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes.

Authors:  Yuesheng Jin; Emely Möller; Karolin H Nord; Nils Mandahl; Fredrik Vult Von Steyern; Henryk A Domanski; Adrian Mariño-Enríquez; Linda Magnusson; Jenny Nilsson; Raf Sciot; Christopher D M Fletcher; Maria Debiec-Rychter; Fredrik Mertens
Journal:  Genes Chromosomes Cancer       Date:  2012-02-15       Impact factor: 5.006

2.  Angiofibroma of soft tissue: clinicopathologic characterization of a distinctive benign fibrovascular neoplasm in a series of 37 cases.

Authors:  Adrián Mariño-Enríquez; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2012-04       Impact factor: 6.394

Review 3.  Kinase inhibitors: the road ahead.

Authors:  Fleur M Ferguson; Nathanael S Gray
Journal:  Nat Rev Drug Discov       Date:  2018-03-16       Impact factor: 84.694

Review 4.  Multifunctional Abl kinases in health and disease.

Authors:  Aaditya Khatri; Jun Wang; Ann Marie Pendergast
Journal:  J Cell Sci       Date:  2016-01-01       Impact factor: 5.285

5.  The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: a molecular genetic study of eight cases.

Authors:  J Lasota; J F Fetsch; A Wozniak; B Wasag; R Sciot; M Miettinen
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

6.  EnABLing Tumor Growth and Progression: Recent progress in unraveling the functions of ABL kinases in solid tumor cells.

Authors:  Rakshamani Tripathi; Zulong Liu; Rina Plattner
Journal:  Curr Pharmacol Rep       Date:  2018-07-23

7.  Sclerosing perineurioma: a clinicopathological study of five cases and diagnostic utility of immunohistochemical staining for GLUT1.

Authors:  Umio Yamaguchi; Tadashi Hasegawa; Takanori Hirose; Kazunori Fugo; Tomoko Mitsuhashi; Michio Shimizu; Akira Kawai; Yasumasa Ito; Hirokazu Chuman; Yasuo Beppu
Journal:  Virchows Arch       Date:  2003-06-26       Impact factor: 4.064

8.  Soft tissue perineuriomas in children: report of three cases and review of the literature [corrected].

Authors:  Fabiola S Balarezo; Richard C Muller; Richard G Weiss; Timothy Brown; David Knibbs; Vijay V Joshi
Journal:  Pediatr Dev Pathol       Date:  2003-01-28

Review 9.  A comprehensive review of protein kinase inhibitors for cancer therapy.

Authors:  Radhamani Kannaiyan; Daruka Mahadevan
Journal:  Expert Rev Anticancer Ther       Date:  2018-10-09       Impact factor: 4.512

10.  Recurrent Genomic Alterations in Soft Tissue Perineuriomas.

Authors:  Jodi M Carter; Yanhong Wu; Melissa M Blessing; Andrew L Folpe; Erik C Thorland; Robert J Spinner; Mark E Jentoft; Chen Wang; Saurabh Baheti; Zhiyv Niu; Michelle L Mauermann; Christopher J Klein
Journal:  Am J Surg Pathol       Date:  2018-12       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.